Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (Q50495776)
Jump to navigation
Jump to search
scientific article published on 4 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. |
scientific article published on 4 June 2012 |
Statements
1 reference
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (English)
1 reference
1 reference
Ronald S Go
1 reference
Tina Marie Green
1 reference
Ken H Young
1 reference
Carlo Visco
1 reference
Zijun Y Xu-Monette
1 reference
Attilio Orazi
1 reference
Ole Nielsen
1 reference
Ole V Gadeberg
1 reference
Torben Mourits-Andersen
1 reference
Mikael Frederiksen
1 reference
Lars Møller Pedersen
1 reference
4 June 2012
1 reference
30
1 reference
3460-3467
1 reference
28
1 reference
Identifiers
1 reference